One Good Idea

Changing How AIDS Funding Is Used

Professor Emily Mendenhall proposes new plan to battle the diseases that can worsen AIDS.

National Journal
July 10, 2015, 1 a.m.

Emily Mend­en­hall, a pro­fess­or of glob­al health at Geor­getown Uni­versity’s Ed­mund A. Walsh School of For­eign Ser­vice, has de­veloped an idea that she hopes will help solve an on­go­ing health crisis in Sub-Saha­ran Africa. Mend­en­hall pro­poses that the Pres­id­ent’s Emer­gency Plan for AIDS Re­lief (PEP­FAR) fund treat­ment for non­com­mu­nic­able dis­eases—such as dia­betes and hy­per­ten­sion—in ad­di­tion to an­ti­ret­ro­vir­al treat­ment, which PEP­FAR has provided for more than 10 years. I re­cently spoke with Mend­en­hall, who has con­duc­ted re­search on poverty, de­pres­sion, and dia­betes in vul­ner­able pop­u­la­tions in Sub-Saha­ran Africa. Our ex­change has been ed­ited and con­densed. (Maria Fab­riz­io)

What spe­cif­ic prob­lem does your pro­pos­al try to solve? In 2004, George Bush cre­ated the Pres­id­ent’s Emer­gency Plan for AIDS Re­lief to ad­dress the glob­al HIV/AIDS epi­dem­ic, primar­ily in Africa. At that time, HIV/AIDS in Sub-Saha­ran Africa and in low- and middle-in­come coun­tries was a clear emer­gency. These funds de­livered an­ti­ret­ro­vir­al treat­ment and ab­so­lutely trans­formed the land­scape. Through this in­cred­ible amount of fund­ing for HIV treat­ment, many people walked away from their deathbed.

A dec­ade later, HIV has changed from an emer­gency to a chron­ic in­fec­tious dis­ease, largely be­cause people are now able to live longer and health­i­er lives on an­ti­ret­ro­vir­al treat­ment. But many are start­ing to suf­fer from in­fec­tious and non­com­mu­nic­able dis­eases, such as stroke, heart dis­ease, dia­betes, and men­tal-health is­sues, in ad­di­tion to HIV. There has been an in­crease in non­com­mu­nic­able dis­ease among the poor in low- and middle-in­come coun­tries, es­pe­cially among the HIV-in­fec­ted and HIV-af­fected, be­cause as these coun­tries be­come more eco­nom­ic­ally ad­vanced and people live longer and come out of poverty, people’s life­styles change sig­ni­fic­antly. For ex­ample, many people who trans­ition from work­ing in the field to the city may have to travel an hour across the city, and will of­ten find them­selves eat­ing on the go and con­sum­ing fried fatty foods along the streets. This is a com­mon nar­rat­ive that leads to wide­spread obesity, from which emerges hy­per­ten­sion and dia­betes, as well as men­tal-health is­sues. 

Hav­ing chron­ic ill­ness, es­pe­cially two severe chron­ic ill­nesses, can be really com­plic­ated. These dis­eases re­quire con­sist­ent man­age­ment. So if you have HIV, you are go­ing to have to go to the hos­pit­al quite of­ten for test­ing. But let’s say you have dia­betes as well. Dia­betes also re­quires go­ing to the hos­pit­al a lot. The prob­lem is that in a lot of health sys­tems, you don’t just go to one doc­tor to test all of your dis­eases; you go to dif­fer­ent clin­ics for every dis­ease. 

What are PEP­FAR’s cur­rent policies? The le­gis­la­tion and fund­ing have not kept pace with the epi­demi­ology. PEP­FAR says they’re try­ing to bring com­pre­hens­ive HIV treat­ment, but they’re not con­sid­er­ing co-mor­bid­it­ies or multi-mor­bid­it­ies. The in­ter­na­tion­al policy is cur­rently ex­clus­ively fo­cused on dis­ease-spe­cif­ic pro­grams. There is a lot of polit­ic­al re­cog­ni­tion of the im­pact of over­look­ing non­com­mu­nic­able dis­eases, but the glob­al health fund­ing doesn’t re­cog­nize this.

How Do you pro­pose that PEP­FAR change? The best thing that PEP­FAR could do for this chan­ging epi­demi­olo­gic­al land­scape would be to provide care for all the dis­eases that people who are HIV-pos­it­ive have. Al­though its le­gis­la­tion doesn’t cur­rently al­low for this, PEP­FAR needs to care for people as people, not simply as people with HIV dis­ease. If someone who’s HIV pos­it­ive also has dia­betes, hy­per­ten­sion, and de­pres­sion, they should get care for all of their prob­lems, not just their CD4 count. Over­look­ing those dis­eases is a death sen­tence in the long term. Their un­treated dia­betes is go­ing to af­fect their HIV dis­ease. 

We need to fund health sys­tems to provide com­pre­hens­ive health care to the poor. If every­one who com­mits to glob­al health could trans­form their fund­ing in­to build­ing health sys­tems, there would prob­ably be few­er short-term ad­vances and suc­cesses, but there would be many more long-term suc­cesses. You want to bring ex­traordin­ary suc­cess to the im­me­di­ate need as well as the long-term need.

What We're Following See More »
Mueller: No Evidence of Collusion
15 hours ago

"The investigation led by Robert S. Mueller III found that neither President Trump nor any of his aides conspired or coordinated with the Russian government’s 2016 election interference, according to a summary of the special counsel’s findings made public on Sunday by Attorney General William P. Barr. The summary also said that the special counsel’s team lacked sufficient evidence to establish that President Trump illegally obstructed justice, but added that Mr. Mueller’s team stopped short of exonerating Mr. Trump." Read Barr's summary here.

Barr Releases Mueller Summary Letter to Congrees
16 hours ago
Mueller Reports
2 days ago

"The special counsel, Robert S. Mueller III, has delivered a report on his inquiry into Russian interference in the 2016 election to Attorney General William P. Barr ... Barr told congressional leaders in a letter late Friday that he may brief them within days on the special counsel’s findings. 'I may be in a position to advise you of the special counsel’s principal conclusions as soon as this weekend,' he wrote in a letter to the leadership of the House and Senate Judiciary committees. It is up to Mr. Barr how much of the report to share with Congress and, by extension, the American public. The House voted unanimously in March on a nonbinding resolution to make public the report’s findings, an indication of the deep support within both parties to air whatever evidence prosecutors uncovered."


Welcome to National Journal!

You are currently accessing National Journal from IP access. Please login to access this feature. If you have any questions, please contact your Dedicated Advisor.